13F Holdings
中文EN

CHUC Charlie's Holdings, Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1134765 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY266.1%
TTM net income YoY-222.5%
TTM EPS YoY-171.4%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—

Margins

Gross margin27.4%
Operating margin-10.8%
Net margin-7.9%
FCF margin—
EBITDA margin-10.7%

Returns

ROE-73.5%
ROA-20.9%
ROIC (approx.)-126.2%
Asset turnover2.63x

Leverage & solvency

Liabilities / assets75.5%
Debt / equity0.00x
Current ratio1.65x
Interest coverage-9.86x

Cash quality & payout

Operating cash flow / net income2.15x
Accruals ratio23.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$20.92M$7.76M$16.25M$26.42M$21.50M
Cost of revenue$15.26M$4.89M———
Gross profit$5.66M$2.88M———
R&D expense——$169,000$804,000$24,000
SG&A expense$6.37M$5.61M$6.97M$8.38M$8.75M
Operating income-$2.17M-$3.30M-$2.20M-$1.80M$565,000
Interest expense$692,000$703,000$477,000$155,000$34,000
Pretax income$4.59M-$4.00M-$2.09M-$1.68M$5.15M
Income tax$275,000$0$0-$92,000$342,000
Net income$4.50M-$4.16M-$2.09M-$1.59M$4.81M
EBITDA-$2.13M-$3.20M-$2.05M-$1.51M$775,000
EPS (basic)0.02-0.02-0.01-0.010.02
EPS (diluted)0.02-0.02-0.01-0.010.01
Weighted avg. shares (diluted)278.54M234.80M216.05M212.27M237.69M
Balance sheet
Cash & equivalents$1.32M$211,000$367,000$257,000$866,000
Receivables$440,000$331,000$289,000$1.16M$1.37M
Inventory$6.72M$2.13M$3.83M$3.65M$5.00M
Current assets$10.77M$3.72M$5.09M$5.85M$7.99M
PP&E, net$37,000$53,000$157,000$311,000$431,000
Total assets$11.56M$3.94M$5.77M$7.06M$9.25M
Current liabilities$7.63M$5.58M$4.75M$4.78M$5.53M
Long-term debt—$2.16M$2.46M$1.45M$150,000
Total debt—$2.16M$2.46M$1.45M$150,000
Total liabilities$8.14M$5.72M$5.88M$5.36M$6.12M
Shareholders' equity$3.42M-$1.78M-$107,000$1.70M$3.13M
Net debt—$1.95M$2.10M$1.19M-$716,000
Shares outstanding270.65M257.29M228.54M219.16M210.89M
Cash flow statement
Operating cash flow-$5.78M-$1.62M-$783,000-$1.72M-$1.35M
Capital expenditure$23,000$0$0$189,000$110,000
Free cash flow-$5.80M-$1.62M-$783,000-$1.91M-$1.46M
Investing cash flow$7.48M$0$0-$189,000-$110,000
Financing cash flow-$590,000$1.47M$893,000$1.30M$901,000
Depreciation & amortization$39,000$102,000$154,000$296,000$210,000
Stock-based compensation$186,000$230,000$286,000$161,000$552,000
Dividends paid———$0$883,000

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.